- Corporate Officers - S
- Smith Christopher M
Insider Trading History of Smith Christopher M
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Smith Christopher M since 2014.
This trader's CIK number is 1436707.
At the time of last reporting, Smith Christopher M was the Chief Executive Officer of Neogenomics Inc. (stock ticker symbol NEO).
Also see all insider trading activities at Neogenomics Inc.
Note that in the past
Smith Christopher M also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Neogenomics Inc (NEO) by Smith Christopher M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | NEO | 0 | $0 | 0 | $0 | 57,413 | $0 |
| 2024 | NEO | 0 | $0 | 0 | $0 | 96,126 | $0 |
Yearly summary of insider trading at Universal Biosensors Inc (UBI) by Smith Christopher M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | UBI | 30,000 | $337,498,500 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Ortho Clinical Diagnostics Holdings Plc (OCDX) by Smith Christopher M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | OCDX | 0 | $0 | 100,000 | $2,109,800 | 100,000 | $1,256,000 |
| 2021 | OCDX | 0 | $0 | 270,000 | $5,890,413 | 0 | $0 |
Insider trading activities at 3 companies by Smith Christopher M:
1. Neogenomics Inc (NEO)
2. Universal Biosensors Inc (UBI)
3. Ortho Clinical Diagnostics Holdings Plc (OCDX)
Table 1. Insider trading of Neogenomics Inc (NEO) by Smith Christopher M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-02-23 | NEO | Option Ex | 57,413 | .00 | 0 |
| 2024-05-11 | NEO | Option Ex | 96,126 | .00 | 0 |
Table 2. Insider trading of Universal Biosensors Inc (UBI) by Smith Christopher M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-05-06 | UBI | Buy | 30,000 | 11,249.95 | 337,498,500 |
Table 3. Insider trading of Ortho Clinical Diagnostics Holdings Plc (OCDX) by Smith Christopher M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-01-03 | OCDX | Sale | 100,000 | 21.10 | 2,109,800 |
| 2022-01-03 | OCDX | Option Ex | 100,000 | 12.56 | 1,256,000 |
| 2021-08-04 | OCDX | Sale | 61,800 | 21.79 | 1,346,622 |
| 2021-08-03 | OCDX | Sale | 104,987 | 21.55 | 2,262,784 |
| 2021-08-02 | OCDX | Sale | 103,213 | 22.10 | 2,281,007 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Smith Christopher M
(Chief Executive Officer of Neogenomics Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.